Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AVTX
AVTX logo

AVTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AVTX News

Avalo to Offer 19.73 Million Shares at $17.75 Each

4d agostocktwits

Avalo Therapeutics Prices Public Offering at $375M

4d agoseekingalpha

Avalo Therapeutics Prices Public Offering at $17.75 per Share

4d agoNewsfilter

Avalo Plans to Advance Abdakibart into Late-Stage Registration

5d agostocktwits

Avalo Therapeutics Reports FY EPS Beat Despite Revenue Decline

Mar 23 2026seekingalpha

Avalo Therapeutics Completes Enrollment for AVTX-009 Trial

Feb 02 2026Benzinga

Valvoline Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations

Dec 18 2025Benzinga

Avalo Therapeutics Reveals Inducement Grants for New Hires in Accordance with Nasdaq Listing Rule 5635(c)(4)

Nov 17 2025Newsfilter

AVTX Events

05/06 07:10
Joint Underwriters Set Deal Range at $17.25-$17.75
The deal range was $17.25-$17.75. Leerink, TD Cowen and BofA acted as joint book running managers for the offering.
05/05 17:30
Leerink, TD Cowen and BofA Jointly Manage New Offering
Leerink, TD Cowen and BofA are acting as joint book running managers for the offering.

AVTX Monitor News

Avalo Therapeutics Prices Public Offering at $17.75 per Share

May 06 2026

AVTX Earnings Analysis

No Data

No Data

People Also Watch